Your Notifications
All done, no notifications

Rhabdomyosarcoma (RMS) Treatment Cost in Tunisia

USD 8000 - USD 14000

Affordable World-class Treatment - Accredited Hospitals - Free Treatment Plan in 24 Hrs

5
Days in Hospital
2-6 hrs*
Procedure Time
70 - 80%
Success Rate
Get Free Treatment Plan Connect with an Expert
JCI/ISO 100,000+ Patients 24X7 Coordinator Visa & Travel handled
Your all-in-one medical travel platform for treatment, recovery & care.

Get Your Personalised Treatment Plan in Just 24 Hours.

Share your details to receive a personalised treatment plan, estimated costs, hospital recommendations, and expert guidance, “completely free.”

Required | alphabets and spaces
Required | A valid, working email address
Required | A valid contact
Connect with an Expert

Your information is protected with HIPAA-compliant security standards. We only share your details with hospitals after your consent.

Estimated Treatment Cost
USD 8000 - USD 14000
All-inclusive • Hospital + Medications + Recovery Assistance + Dedicated Care Coordinator
International Quality. Affordable Care.

What's included in your Rhabdomyosarcoma (RMS) Treatment quote?

Pediatric oncology consultation
Initial evaluation, diagnosis review, and personalised treatment planning
Pediatric Sarcoma Specialists
Blood tests, biopsy review, MRI/CT/PET-CT, and staging investigations
Hospital stay + ICU as needed
Inpatient care, nursing, symptom management, and supportive treatment
Hospital stay monitoring
Imaging, laboratory tests, and oncology consultations to monitor recovery
Visa & medical-visa invite letter
Airport pickup & transfers
Get Itemized Quote FREE

Cost of Rhabdomyosarcoma (RMS) Treatment in Major Cities of Tunisia

CityCost (USD)
Tunis $15,000 – $32,000 Explore More

Rhabdomyosarcoma Rms Treatment - Tunisia Vs the World

India
$5k - $0
United Arab Emirates
$5k - $0
Vietnam
$8k - $20k
Turkey
$18k - $40k
Malaysia
$22k - $45k
Thailand
$22k - $50k
Saudi Arabia
$25k - $55k
South Korea
$30k - $70k
Spain
$30k - $80k
United Kingdom
$30k - $65k
Israel
$50k - $90k
Singapore
$75k - $150k
Fauzia Zeb Fatima
Author

Fauzia Zeb Fatima

M.Pharm

4 Years of Experience

Fauzia Zeb is a distinguished medical and scientific content writer with a robust academic foundation in pharmaceutical sciences, holding a B.Pharm and M.Pharm degree from prestigious institutions, including MIT and Jamia Hamdard University. Her comprehensive expertise in pharmacology, clinical sciences, and biomedical research enables her to translate complex medical and scientific concepts into precise, evidence-based content tailored for diverse audiences. Specializing in peer-reviewed articles, clinical blog posts, and research-driven publications, she demonstrates a consistent ability to bridge the gap between advanced medical science and accessible, audience-specific communication.
View More
Dr Prateek Varshney
Reviewer

Dr Prateek Varshney

Surgical Oncologist

15 Years of Experience

Last Reviewed - June 2026

Dr. Prateek Varshney is a renowned Surgical Oncologist. He has experience of more than 15+ years in surgical Oncology. He is currently practicing as a consultant at Metro Mass Hospital and Cancer Institute. He was also previously associated as a consultant with Sir Ganga Ram Hospital and as a professor at Gujarat Cancer Research Institute.
View More

Need Help Choosing the Right Treatment? Talk to a Medical Advisor

Our dedicated Medical Patient Advisors are here to answer your questions, help you compare treatment options, estimate costs, and guide you through every step of your healthcare journey.

Connect with an Expert Request a Free Consultation
15 min
Average response time
Serving Patients Worldwide in Multiple Languages.

Commonly affecting children and young adults, rhabdomyosarcoma (RMS) is an uncommon and aggressive form of soft tissue cancer that arises in skeletal muscle cells. Treatment for rhabdomyosarcoma (RMS) includes radiation therapy to stop recurrence, chemotherapy to reduce or eradicate cancer cells, and surgery to remove the tumor. In certain situations, immunotherapy or targeted therapy may be employed. Rehabilitation and pain management are supportive care that enhances a patient's quality of life.

Explore Hospitals ( 1 )

Tunis, Tunisia

120+ Beds · 134+ Procedures
Starting
USD 8000

Get Your Rhabdomyosarcoma (RMS) Treatment
Plan in 24 hrs.

Our experienced Medical Patient Advisors have supported 100,000+ patients across 120+ countries with personalised treatment plans, hospital recommendations, cost estimates, and travel assistance, all free.

HIPAA-Compliant Data SecurityShared Only with Your Consent

✓ Free Consultation ✓ No Obligation ✓ Personalized Treatment Plan ✓ Response Within 24 Hours

Required | alphabets and spaces
Required | A valid, working email address
Required | A valid contact

Your medical info is kept HIPAA-style confidential. We never share with hospitals without your consent.

Jenny Wilson
Your Dedicated Medical Patient Advisor
Treatment planning • Hospital coordination • Multilingual support • Response within 15 minutes.
Connect with an Expert Book 15-min call
Our Services to Better your Experience

Opinion & Option

We submit the most accurate opinion and options from one or more countries for your review

Consult Privately

Consult with a certified specialist privately on our telemedicine platform even before you decide to travel

Logistics

We handle flights, visas, transfers, and accommodation—so you can focus on your health.

Recovery

Our In-house rehabilitation service packages to better your recovery and treatment outcome

Patient Stories

Ms. Monica
Ms. Monica
Monica from Ghana for AV Malformation Treatment in India

Monica from Ghana suffered from AV malformation. She decided to look for options for medical treatment when she started experiencing…

Watch Story
Silim Shabani
Silim Shabani
Patient Testimonial: Silim Shabani for Ovarian Cancer Treatment in Turkey

Nasrin (Sister of the patient ) explains the journey of how MediGence helped for the treatment of Silim Shabani for…

Watch Story

Frequently Asked Questions

The cost of Rhabdomyosarcoma (RMS) Treatment in Tunisia may vary depending on the tumour subtype, disease stage, tumour location, diagnostic investigations, treatment approach, hospital charges, specialist consultation fees, surgery, chemotherapy, radiation therapy, supportive care, and duration of treatment. The overall cost may include specialist consultations, imaging studies, biopsy, pathology, surgery when indicated, chemotherapy, radiation therapy, hospitalisation, medications, rehabilitation, and follow-up care.MediGence can help international patients explore suitable oncology centres and obtain an estimated treatment plan based on the patient's diagnosis, disease stage, and clinical requirements.

The best hospitals in Tunisia for Rhabdomyosarcoma (RMS) Treatment are those with experienced paediatric oncologists, medical oncologists, surgical oncologists, radiation oncologists, orthopaedic oncologists, radiologists, pathologists, and multidisciplinary sarcoma teams. Patients should consider hospitals with dedicated sarcoma programmes, advanced diagnostic imaging, modern radiation therapy facilities, paediatric oncology expertise where required, and comprehensive rehabilitation and supportive care services.

Patients should choose a paediatric oncologist, medical oncologist, or sarcoma specialist experienced in treating soft tissue sarcomas, particularly Rhabdomyosarcoma. Important factors include expertise in multimodal treatment, tumour surgery, chemotherapy protocols, precision radiation therapy, and long-term survivorship care.The treating team should evaluate biopsy findings, tumour location, histological subtype, imaging studies, disease stage, metastatic status, overall health, and treatment goals before recommending an individualised treatment plan.

Rhabdomyosarcoma (RMS) Treatment has an overall success rate of approximately 70–90%, depending on the tumour subtype, disease stage, tumour location, patient age, response to treatment, presence of metastasis, and overall clinical condition. Outcomes are generally more favourable when treatment begins early and is delivered at experienced multidisciplinary sarcoma centres.

Hospitals in Tunisia may use MRI, CT scans, PET-CT imaging, ultrasound, bone scans when indicated, image-guided biopsy, molecular pathology, genetic testing, limb-sparing surgical techniques, intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), proton therapy where available, chemotherapy, targeted therapy for selected patients, and comprehensive supportive oncology care.Treatment is typically multidisciplinary and may involve surgery, chemotherapy, radiation therapy, targeted therapy in selected cases, and supportive care based on the tumour characteristics and disease stage.

Possible risks and complications may include:
  • Bleeding
  • Surgical site infection
  • Delayed wound healing
  • Fatigue
  • Nausea and vomiting
  • Hair loss
  • Low blood cell counts and increased infection risk
  • Side effects of radiation therapy
  • Organ-specific complications depending on tumour location
  • Growth and developmental effects in children
  • Fertility-related concerns following certain treatments
  • Cancer recurrence or progression
  • Long-term treatment-related complications
    • The treating oncology team will explain the potential risks based on the patient's diagnosis, treatment plan, age, and overall health.

    Patients or caregivers should share all relevant medical records with the treating oncology team before travelling. These may include biopsy and pathology reports, MRI, CT, PET-CT, or ultrasound reports, blood test results, previous treatment records, medication history, allergy information, and immunisation records for paediatric patients when available.Patients should also discuss the expected treatment duration, accommodation requirements, nutritional support, rehabilitation services, caregiver arrangements, fertility preservation when appropriate, and follow-up plan before making travel arrangements.

    Yes. International patients can arrange an online consultation with a paediatric oncologist or sarcoma specialist before travelling to Tunisia. The specialist may review the patient's pathology reports, imaging studies, disease stage, previous treatments, and overall clinical condition to recommend the most appropriate treatment plan.MediGence can help coordinate online consultations and facilitate the secure sharing of relevant medical records with suitable specialists.

    International patients should carry a valid passport and relevant medical documents, including:
  • Biopsy and pathology reports
  • MRI, CT, PET-CT, or ultrasound reports
  • Bone scan reports, if available
  • Blood test results
  • Previous oncology consultation records
  • Previous surgery, chemotherapy, or radiation therapy records
  • Current prescriptions and medication details
  • Allergy and complete medical history
  • Birth and immunisation records for paediatric patients, if available

    • The required stay in Tunisia depends on the stage of the disease, treatment plan, and recovery. Patients undergoing surgery may require hospitalisation followed by recovery, while chemotherapy and radiation therapy usually require treatment over several weeks or months.Patients may need to remain in Tunisia until the planned treatment cycle is completed, treatment-related side effects are adequately managed, postoperative recovery is satisfactory when applicable, and the treating team confirms that the patient is fit to travel.

    Recovery varies depending on the treatment received and the patient's overall health. Recovery following surgery may take several weeks, while chemotherapy and radiation therapy often require ongoing monitoring and supportive care over several months.Long-term follow-up includes physical examinations, imaging studies, laboratory monitoring, rehabilitation, assessment for tumour recurrence, management of treatment-related side effects, and survivorship care, particularly in paediatric patients.

    If complications occur, patients should contact the treating oncology team or seek immediate medical attention. Prompt evaluation may be required for persistent fever, severe pain, excessive bleeding, wound infection, difficulty breathing, dehydration, uncontrolled vomiting, signs of severe infection, or symptoms suggestive of tumour recurrence or disease progression.Patients should receive detailed discharge instructions, medication guidance, nutritional advice, emergency contact information, rehabilitation recommendations, and a structured oncology follow-up plan before returning home.

    International patients can submit their medical records, pathology reports, and imaging studies through the MediGence website. Following an initial review, the MediGence care team can help patients explore suitable oncology hospitals and experienced sarcoma specialists, coordinate consultations, and support treatment planning and medical travel arrangements.The final treatment recommendation is made by the treating multidisciplinary oncology team after a comprehensive clinical evaluation.

    International patients may choose Tunisia for access to experienced paediatric and adult sarcoma specialists, multidisciplinary cancer centres, advanced diagnostic imaging, modern surgical techniques, precision radiation therapy, comprehensive chemotherapy services, rehabilitation programmes, and long-term survivorship care.The destination should be evaluated based on physician expertise, hospital accreditation, patient safety standards, access to advanced cancer therapies, and experience in managing rare soft tissue sarcomas.

    Treatment options depend on the tumour subtype, stage, location, metastatic status, age, and overall health. Options may include:
  • Surgical tumour removal
  • Limb-sparing surgery, when feasible
  • Chemotherapy
  • Radiation therapy
  • Intensity-Modulated Radiation Therapy (IMRT)
  • Proton therapy, where available
  • Targeted therapy for selected patients
  • Clinical trial participation, when appropriate
  • Rehabilitation and supportive care
  • Long-term oncology follow-up and survivorship care
    • The treating multidisciplinary oncology team will recommend the most appropriate treatment plan after evaluating the patient's diagnosis and overall clinical condition.

    International patients may choose Tunisia for access to specialised sarcoma centres, experienced multidisciplinary oncology teams, advanced diagnostic technologies, personalised multimodal treatment, comprehensive rehabilitation services, and coordinated long-term follow-up care.MediGence can assist patients with hospital and specialist selection, medical record coordination, consultation scheduling, treatment planning, and travel-related support. The final destination should be selected according to the patient's diagnosis, disease stage, clinical requirements, treatment goals, and the hospital's expertise in Rhabdomyosarcoma (RMS) Treatment.

    Not Sure About Your Treatment Plan? Get a Free Second Opinion

    Have your reports reviewed by independent oncology experts to help you make a confident treatment decision, all online within 48 hours.

    Upload Your Reports
    Free second opinion on your CAR-T plan